Psap Gene Prosaposin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The PSAP gene encodes prosaposin, a crucial lysosomal protein that serves as the precursor for four small lysosomal proteins called saposins (Saposin A, B, C, and D). These saposins are essential cofactors for the hydrolysis of various glycolipids by lysosomal hydrolases[1]. Prosaposin and its derived saposins play critical roles in lipid metabolism, and mutations in PSAP cause severe neurodegenerative lysosomal storage disorders[2]. [1]
Prosaposin is a 557-amino acid glycoprotein that is proteolytically processed in the lysosome to generate four mature saposins[1]: [2]
Each saposin has a specific role in activating different lysosomal hydrolases involved in glycolipid catabolism[1][3]. [3]
Prosaposin and its derived saposins serve multiple critical physiological functions[4]: [4]
Mutations in PSAP cause deficiencies in multiple hydrolases due to lack of saposin cofactors[2][6]: [5]
| Disorder | Enzyme Deficiency | Primary Features | [6]
|----------|------------------|-----------------| [7]
| Combined Saposin Deficiency | Multiple | Severe neurodegeneration, hepatosplenomegaly, fatal early |
| Arylsulfatase A Deficiency (Metachromatic Leukodystrophy) | Cerebroside sulfatase | Demyelination, neurodegeneration |
| Krabbe Disease | Galactocerebrosidase | Severe neurodegeneration, optic atrophy |
| Gaucher Disease Type 3 | Glucocerebrosidase | Neuropathic form with systemic features |
The PSAP gene has been implicated in multiple neurodegenerative conditions beyond classic lysosomal storage disorders[4][7]:
| Variant | Effect | Disease Association |
|---|---|---|
| p.L300P | Missense | Combined saposin deficiency |
| p.D335N | Missense | Metachromatic leukodystrophy modifier |
| p.L349P | Missense | Krabbe disease phenotype |
| c.995delC | Frameshift | Combined deficiency |
| IVS3+1G>A | Splicing | Multiple enzyme deficiencies |
Several therapeutic approaches are being explored for PSAP-related disorders[2][6]:
Prosaposin/saposins interact with multiple lysosomal enzymes and proteins[1][3]:
The study of Psap Gene Prosaposin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Sandhoff R, et al. "Functional analysis of saposin proteins." J Mol Neurosci. J Mol Neurosci. 2001. ↩︎
Svensson E, et al. "Prosaposin and its fragments in neurodegeneration." J Neurosci Res. J Neurosci Res. 2002. ↩︎
Liu J, et al. "PSAP mutations and lysosomal dysfunction in the nervous system." Brain. Brain. 2008. ↩︎
Huang J, et al. "Saposin proteins in the nervous system: role in lipid metabolism and neuroprotection." J Neurochem. J Neurochem. 2011. ↩︎
Vanier MT. "Complex lipid trafficking in lysosomal disorders." J Inherit Metab Dis. J Inherit Metab Dis. 2013. ↩︎
Sun Y, et al. "Prosaposin deficiency causes neurodegeneration through impaired autophagy." Hum Mol Genet. Hum Mol Genet. 2015. ↩︎ ↩︎
Kwon D, et al. "Neuroprotective effects of prosaposin in models of Parkinson's disease." Nat Commun. Nat Commun. 2023. ↩︎ ↩︎
Oligodendrocytes drive neuroinflammation via the prosaposin-GPR37-IL-6 axis in Parkinson's disease. Nature. 2024. ↩︎